Pediatric Speech Therapists at TPMG
Receive Up to $20,000 in Student Loan Repayment.¹
In partnership with Clasp, The Permanente Medical Group is offering eligible employees up to $20,000 in student loan repayment over two years of employment.¹
Contact UsNo catch, no clawbacks. Read the Clasp Student Bill of Rights
For Current TPMG Team Members
A Benefit for TPMG's Pediatric SLPs
Up to $20,000
Paid toward your eligible student loans over 2 years of employment.1
Paid Monthly
Payments go directly to your loan servicer through the Clasp platform.
No Clawbacks
Payments made by TPMG are not subject to clawback under the program.1
Any Eligible Loan
Applies to eligible federal or private education loans supported by Clasp.
Get In Touch
Questions?
Reach out to scholars@clasp.com to learn more, or review the Frequently Asked Questions below.
Contact UsFAQs
¹ Eligibility requirements apply, and program selection is not guaranteed. If qualified, selected, and employed by TPMG for 2 years of employment, TPMG will pay make payments on your behalf toward your eligible student loans in monthly installments via the Clasp platform up to a maximum of $20,000.
Any payments made by your employer are not subject to clawback—you do not have to repay them to the employer under the program.
However, you are still responsible for your student loan/s. If you voluntarily leave your job, are terminated for cause, or do not meet the terms of your employment or repayment agreement, your employer will stop making payments, and you will resume making payments on your remaining loan balance. Your agreement with your employer is separate from your loan obligation, and your responsibility to your lender remains unless payments are made by your employer or another party on your behalf.
² You may be subject to income tax for some or all of the loan payments made by TPMG on your behalf. You should consult with a tax professional if you have any questions regarding tax consequences of the TPMG Loan Repayment Program.
Information valid as of October 9, 2026.